Edgewise Therapeutics earnings were -$146.1M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest EWTX earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$40.8M, up 2.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, EWTX reported annual earnings of -$133.8M, with 33.6% growth. The next EWTX earnings date is Aug 7, 2025.
Edgewise Therapeutics Earnings Reports & History FAQ
What were Edgewise Therapeutics's earnings last quarter?
On EWTX's earnings call on Invalid Date, Edgewise Therapeutics (NASDAQ: EWTX) reported Q1 2025 earnings per share (EPS) of -$0.43, up 30.3% year over year. Total EWTX earnings for the quarter were -$40.80 million. In the same quarter last year, Edgewise Therapeutics's earnings per share (EPS) was -$0.33.
The next EWTX earnings date is Invalid Date. Add EWTX to your watchlist to be reminded of Edgewise Therapeutics's next earnings date.
Is Edgewise Therapeutics profitable or losing money?
As of the last Edgewise Therapeutics earnings report, Edgewise Therapeutics is currently losing money. Edgewise Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$146.09 million, a 38.01% increase year over year.
What was EWTX's earnings growth in the past year?
As of Edgewise Therapeutics's earnings date in Invalid Date, Edgewise Therapeutics's earnings has grown year over year. EWTX earnings in the past year totalled -$146.09 million.
What are Edgewise Therapeutics's earnings expectations?
The current EPS estimate for Edgewise Therapeutics's earnings report in Invalid Date is -$0.42.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.